Portfolio (Quarterly)
Guide ↗
DEERFIELD MANAGEMENT COMPANY, L.P.
· CIK 0001009258| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | ARROWHEAD PHARMACEUTICALS IN | — | 200,000,000.0 | $207.2M | 2.44% | NEW | — | $1.04 | — |
| 2 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 3,097,790.0 | $94.4M | 1.11% | NEW | — | $30.48 | +24.1% |
| 3 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 3,779,900.0 | $88.3M | 1.04% | NEW | — | $23.36 | -12.0% |
| 4 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1,019,813.0 | $85.6M | 1.01% | NEW | — | $83.92 | +1.7% |
| 5 | PFE | PFIZER INC | Healthcare | 3,040,000.0 | $85.4M | 1.01% | NEW | — | $28.08 | -8.3% |
| 6 | — | ZENAS BIOPHARMA INC | — | 65,000,000.0 | $67.3M | 0.79% | NEW | — | $1.03 | — |
| 7 | GMAB | GENMAB A/S | Healthcare | 2,462,000.0 | $66.1M | 0.78% | NEW | — | $26.83 | +0.3% |
| 8 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 851,556.0 | $48.1M | 0.57% | NEW | — | $56.49 | -8.3% |
| 9 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 549,000.0 | $21.0M | 0.25% | NEW | — | $38.30 | -4.7% |
| 10 | — | BRIGHT MINDS BIOSCIENCES INC | — | 283,000.0 | $20.7M | 0.24% | NEW | — | $72.97 | — |
| 11 | SGP | SPYGLASS PHARMA INC | Healthcare | 550,000.0 | $14.3M | 0.17% | NEW | — | $25.91 | -6.3% |
| 12 | MANE | VERADERMICS INC | Healthcare | 5,000.0 | $316K | 0.00% | NEW | — | $63.15 | +69.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%